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Introduction Pharmacies and drug stores are frequently 
patients’ first point of care in many low-income and 
middle-income countries, but their practice is often 
poor. Pharmacy retailing in India has traditionally been 
dominated by local, individually owned shops, but recent 
years have seen the growth of pharmacy chains. In theory, 
lower-powered profit incentives and self-regulation to 
preserve brand identity may lead to higher quality in chain 
stores. In practice, this has been little studied.
Methods We randomly selected a stratified sample of 
chain and independent pharmacies in urban Bengaluru. 
Standardised patients (SPs) visited pharmacies and 
presented a scripted case of diarrhoea for a child 
and suspected tuberculosis (TB). SPs were debriefed 
immediately after the visit using a structured 
questionnaire. We measured the quality of history 
taking, therapeutic management and advice giving 
against national (Government of India) and international 
(WHO) guidelines. We used Pearson’s χ2 tests to 
examine associations between pharmacy type and case 
management.
Findings Management of childhood diarrhoea and 
suspected TB was woefully substandard. History taking of 
the SP was limited; unnecessary and harmful medicines, 
including antibiotics, were commonly sold; and advice 
giving was near non-existent. The performance of 
chains and independent shops was strikingly similar for 
most areas of assessment. We observed no significant 
differences between the management of suspected TB 
in chains and independents. 43% of chains and 45% 
of independents managed the TB case correctly; 17% 
and 16% of chains and independents, respectively, sold 
antibiotics. We found that chains sold significantly fewer 
harmful antibiotics and antidiarrhoeals (35% vs 48%, 
p=0.029) and prescription-only medicines (37% vs 49%, 
p=0.048) for the patient with diarrhoea compared with 
independent shops. Not a single shop managed the patient 
with diarrhoea correctly according to guidelines.
conclusion Our results from Bengaluru suggest that it 
is unlikely that chains alone can solve persisting quality 
challenges. However, they may offer a potential vehicle 
through which to deliver interventions. Future intervention 
research should consider recruiting chains to see whether 
effectiveness of interventions differ among chains 
compared with independents.
IntroductIon
It has been widely established that the care 
received from pharmacies in many low-income 
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Key questions
What is already known about this topic?
 ► It is widely reported that pharmacy practice in many 
low-income and middle-income countries (LMICs) 
is substandard.
 ► Chain pharmacies are expanding in India and other 
LMICs.
 ► Economic theory predicts that chains may positively 
affect quality, but very little is known about this in 
practice in pharmacy markets.
What are the new findings?
 ► Quality of care for childhood diarrhoea and 
suspected tuberculosis, as measured by ideal 
case management of standardised patients and 
adherence to recommended history-taking and 
advice-giving lists, was found to be equally poor in 
chains and independent pharmacies in Bengaluru, 
India.
 ► Chains sold significantly fewer prescription-only 
medicines and those deemed ‘harmful’ for the 
patient with diarrhoea, compared with independent 
shops.
recommendations for policy
 ► Introduction of chains alone is unlikely to address 
quality challenges in this context. 
 ► Interventions to improve effectivess should be 
delivered through chains to see whether they yield 
different results compared to individual shops.
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and middle-income countries (LMICs) is inadequate, 
despite frequently being patients’ first point of contact 
with the healthcare system.1–3 All too often, medicine use 
in these settings is ‘irrational’. That is, patients do not 
receive the appropriate medicines, in doses that meet 
their individual requirements, for an adequate duration, 
and at the lowest cost.4 Irrational medicine use is a major 
public health concern, which contributes to unneces-
sary morbidity and mortality; fuels the growing threat 
of antimicrobial resistance (AMR); and leads to need-
less spending.5 AMR has garnered particular interest of 
late. WHO has declared it a ‘global health security emer-
gency’, and 193 heads of states and governments have 
pledged to address the concern through a UN declara-
tion.6 7 In approaches to prevent the situation worsening, 
pharmacies should arguably be a key focus.
In recent years, there has been a growing interest in 
pharmacy chains in LMIC contexts.8–10 India, in partic-
ular, has seen prolific expansion of the corporate phar-
macy retail sector.9 In theory, there are reasons to believe 
that chains may positively influence key determinants of 
treatment behaviour, notably the regulatory environment 
and profit incentives faced by staff.3 The fragmented 
nature of retail pharmacy in India makes enforcing regu-
lation costly and logistically difficult. Through consolida-
tion, chains could improve regulation in two ways. State 
regulation can be concentrated on central management 
structures; essentially, the regulator can make firms 
take responsibility for local branches. Second, firms 
may self-regulate in order to preserve brand identity.11 
Another reason why quality may improve in a chain situ-
ation concerns incentive structures. Financial incentives 
faced by pharmacy-level personnel working in chains 
are low powered compared with those who own their 
own pharmacy and directly receive the profits of trans-
actions.12 Independent shopkeepers may therefore face 
stronger incentives to engage in irrational medicine use, 
such as selling unnecessary or prescription-only medi-
cines (POMs) without a prescription, where this increases 
their profits.
The question of whether this organisational structure of 
the pharmacy firm affects quality of care remains largely 
untouched by empirical research studies in LMIC. Studies 
from high-income countries report on a wide range of 
outcomes,13–15 but given the strength of regulation in 
high-income contexts, the findings are likely to have 
limited applicability in LMICs. Two studies from Mexico 
report on the sale of misoprostol (to induce abortion). 
One found that chains were less likely to sell misoprostol 
compared with independent shops,16 while the other 
found no significant differences.17 Others examined the 
effect of chain store entry on prices and drug quality in 
the retail pharmacy market in Hyderabad, India, but did 
not assess therapeutic management of patients.18
To address this gap in the literature, this paper reports 
on a study from Bengaluru, South India, which used 
standardised patients (SPs), often considered the ‘gold 
standard’ for quality of care measurement,19 to assess the 
case management of two conditions, in a representative 
sample of chain and independent pharmacies. Symptoms 
of these conditions are commonly presented in pharma-
cies, represent a high burden of disease and are subject 
to key quality concerns in relation to underprovision and 
overprovision of treatment.
Methods
study setting and design
Pharmacy chains are concentrated in populous cities, 
with the greatest concentration in South India. This 
guided the selection of Bengaluru, the capital of Karna-
taka State and India’s third most populous city, as the 
study site.
We used a cross-sectional SP survey to investigate the 
management of suspected tuberculosis (TB) in an adult 
and acute watery diarrhoea in a 2 year old (who was 
not present). WHO recommends non-bacterial diar-
rhoea in children under age 5 as a tracer condition for 
measuring quality of care. Other health problems that 
are either frequently presented or of particular clinical 
or economic importance are also deemed appropriate 
provided that there are clear treatment guidelines.20 21 
In India, TB meets these criteria.22 23 These conditions 
also represent contrasting examples of recommended 
management—pharmacies should refer a suspected TB 
case, whereas diarrhoea is commonly wholly treatable in 
the pharmacy environment.
We trained six research assistants (one female and five 
males) as SPs to visit chain and independent pharmacies. 
SPs were recruited from Bengaluru where the study was 
undertaken. The average age was 31, the youngest being 
20 and the oldest 45. The individuals were trained (in 
a group) by RM (with input from a local researcher) 
over a period of 1 week. Training included learning the 
cases, including much role play, and running through 
the debrief questionnaire in the classroom. All SPs also 
ran through the details of their back-story and practised 
answering questions relating to their personal situation, 
as well as the presentation of the medical case. Each SP 
completed a number of pilot presentations in the field, 
under the supervision of a senior research assistant, until 
we were confident that the cases were being presented 
in a standardised, convincing manner. It was discussed 
among the research team how they should dress to 
ensure their social background appeared similar to a 
typical customer who might present such cases.
The SPs presented a rehearsed, scripted scenario, 
in Kannada (the local language), of both conditions, 
during a single visit, at a random sample of pharmacies. 
SPs purchased any recommended medications. Immedi-
ately after each pharmacy visit, they were debriefed using 
a structured questionnaire. We measured the quality of 
case management based on national and international 
guidelines. For the TB case, we used Government of 
India (GOI) and the Indian Pharmaceutical Association 
guidelines for community pharmacists.23 In the absence 
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Table 1 Standardised patient case details and expected management
Case details Expected management
Case description Details of scenario History Treatment Advice
Acute watery diarrhoea 
in a child
“I need to buy 
something for my niece 
who has diarrhoea. She 
is 2 years old?”
Further questioning 
would reveal:
 ► Four episodes during 
the last day;
 ► More thirsty than 
usual;
 ► May have had a 
slight fever;
 ► No blood in the stool, 
abdominal pain or 
vomiting;
 ► No medication had 
been taken.
Pharmacy server to ask:
 ► Blood in stool?
 ► Duration of 
diarrhoea?
 ► Number of stools per 
day?
 ► Number of episodes 
of vomiting?
 ► Presence of fever?
 ► Preillness feeding 
practices?
 ► Type of fluids and 
foods during illness?
 ► Child passing urine?
 ► Tried any 
medication?
 ► Oral rehydration 
therapy using ORS 
solution;
 ► Zinc 
supplementation;
 ►  No sale of 
antidiarrhoeals, 
antibiotics or 
antispasmodics.
 ► Explain how to use 
ORS;
 ► Importance of more 
fluids;
 ► Usual diet should be 
continued (including 
milk);
 ► Take to health 
worker if signs of 
dehydration or 
other problems, for 
example, blood in 
stool.
Suspected pulmonary 
tuberculosis in an adult
On completion of 
diarrhoea advice: “Also 
for myself… I have 
had cough and some 
fever for 3–4 weeks. We 
have had a relative 
staying with us who has 
TB. Can you suggest 
something?”
Further questioning 
would reveal:
 ► Sputum in the 
cough;
 ► Sweating at night;
 ► Loss of appetite;
 ► No medication had 
been taken.
Pharmacy server to ask:
 ► Consulted doctor?
 ► Chest pain?
 ► Sputum or blood in 
cough?
 ► Weakness or 
fatigue?
 ► Weight loss?
 ► Loss of appetite?
 ► Chills?
 ► Night sweats?
 ► Any other 
symptoms?
 ► Tried any 
medication?
 ► Referral to TB clinic 
or other healthcare 
provider for sputum 
examination;
 ► No sale of antibiotics 
(including anti-TB 
medication) or 
steroids.
 ► Advise that treatment 
is available free 
of charge from 
government 
hospitals.
ORS, oral rehydration salts; TB, tuberculosis.
of any pharmacy-specific Indian or international guide-
lines for the management of diarrhoea, we based our 
assessment on WHO guidelines (also adopted by GOI) 
aimed at ‘physicians and other senior health workers’.24 25 
These can be argued to be appropriate for pharmacy 
staff as India’s ‘Pharmacy Practice Regulations’ include 
as responsibilities of community pharmacists ‘selling 
over-the-counter medicines; counselling and advising 
the public on the treatment of minor ailments’,26 and 
the diarrhoea case presented here can be considered a 
minor ailment.
cases
Table 1 provides an overview of the cases, how the SPs 
presented them and the expected course of action against 
which we measured their management. According to the 
guidelines, community pharmacists should refer patients 
with symptoms suggestive of TB for sputum examination. 
They should not sell medicines that require a prescrip-
tion. The sale of medicines from Indian pharmacies is 
governed by the Drugs and Cosmetic Rules 1945. Under 
this act, medicines are categorised as over-the-counter 
(OTC) (no schedule) or prescription-only. There are 
three levels of POMs: H, H1 and X. Schedule H medi-
cines require a prescription from a qualified practitioner. 
Schedule H1 was introduced in 2013 to curb OTC use of 
certain POM medicines (mainly antibiotics). The 46 H1 
medicines are subject to an extra set of conditions on 
dispensing (identity of the patient, contact details of the 
prescriber and the name and dispensed quantity of the 
drug must be recorded in a separate register). Schedule 
X is the most restrictive list, comprising a small number 
of narcotics, for which the pharmacy is required to retain 
the prescription for 2 years.
We considered provision of antibiotics (including 
anti-TB medicines) and/or steroids as ‘harmful’, in 
line with Satyanarayana and colleagues; incomplete and 
unneeded courses of antibiotics could lead to emer-
gence of resistant strains and steroids could mask the 
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Table 2 Size of pharmacy chains in Bengaluru and in 
sample
Outlets (n) Chains (n)
Chains in our 
sample (n)
Outlets in our 
sample (n)
2–5 6 1 1
6–10 2 2 4
11–50 2 2 6
51–100 1 1 14
101+ 2 2 78
symptoms leading to delayed diagnosis.27 A 2-year-old 
child with diarrhoea should be managed with oral rehy-
dration therapy (ORT), supplemental zinc and continued 
feeding of energy-rich foods and breast feeding. Again, 
POMs should not be sold, and in this case, antibiotics, 
antidiarrhoeals and antispasmodics are categorised as 
‘harmful’.25 28 We term medicines not listed in the guide-
lines yet not deemed ‘harmful’ as ‘not recommended’. 
For both cases, we expect pharmacy staff to ask questions 
to confirm the diagnosis and determine appropriate 
treatment and to provide advice.
selection of pharmacies and sample size
We obtained a list of all pharmacies registered in the 
Bengaluru urban district from the Karnataka State Drug 
Control Department. To check the comprehensiveness 
and validity of this list, we completed censuses in three 
neighbourhoods with differing wealth profiles (according 
to local informants). This exercise confirmed that the list 
provided a comprehensive sampling frame (97% accu-
rate). From the list, we then categorised pharmacies 
as either ‘independent’ or ‘chain’. We defined chains 
as organisations where two or more pharmacies were 
operating under the same name and the business used 
distinctive branding across all pharmacies. We excluded 
pharmacies operating inside hospitals or clinics, which 
customers could not access from the street. The resulting 
list contained 5135 independents and 529 chains shops 
deriving from 13 chains (table 2). Subsequently, we 
selected a random sample of pharmacies, stratified by 
type: chain or independent. Our sample included shops 
from eight chains: the largest seven and one chain of the 
2–5 outlet size (details in table 2).
Between May and June 2015, SPs visited 333 phar-
macies across Bengaluru (103 chains and 230 indepen-
dents) and presented both cases at each pharmacy. These 
figures satisfy sample size calculations based on a level 
of significance of 0.05, 80% power, effect size of 0.2 (ie, 
can detect a 20% difference in quality measurements 
between pharmacy types) and a proportion of interest of 
0.5 for the outcome of correct case management.
statistical analysis
We used STATA 14 to analyse the two disease cases sepa-
rately. The unit of analysis was the pharmacy. We used 
Pearson’s χ2 tests to examine the effects of pharmacy 
type (chain vs independent) on history taking, treatment 
recommendations and advice.
ethical approval
The London School of Hygiene and Tropical Medi-
cine Ethics Committee in London, England, and the 
Society of Community Health Awareness Research and 
Action Institutional Scientific and Ethics Committee 
in Bengaluru, India, approved the study. We specifi-
cally sought and received approval to waive obtaining 
informed consent from the pharmacies prior to the SP 
visits.
results
We present the results of the SP survey according to the 
three key aspects of case management specified in table 1.
history taking
Questioning of SPs by pharmacy staff was generally poor 
(table 3), with no significant differences in history taking 
at chain and independent pharmacies. Less than 10% of 
chains and independents asked a single recommended 
question regarding the diarrhoea case. This figure was 
slightly higher for suspected TB with 17% of chains and 
23% of independents asking at least one relevant ques-
tion.
Recommended questions for the suspected TB case are 
primarily to confirm the diagnosis. The most commonly 
asked question was regarding the presence of blood or 
sputum on coughing, asked by 12% of chains and 13% 
of independents. Less than 5% of chains and indepen-
dents asked about action already taken or other ques-
tions to determine diagnosis including the presence of 
night sweats, pain in the chest, fatigue or any other symp-
toms. No shops asked about weight loss, loss of appetite 
or chills.
Correct questioning of the diarrhoea case would rule 
out a more serious underlying condition warranting 
referral for medical attention. No more than 5% of 
chains or independents asked any recommended ques-
tions. Not a single shop made enquiries regarding reme-
dies already taken, fluid and food intake of the child 
either before or since falling ill or the presence of blood 
in the stool.
therapeutic management
Figure 1 (and online supplementary appendix A1 for 
corresponding table) shows that SPs received correct 
management of the suspected TB case in 43% and 
45% of chain and independent shops, respectively. We 
observed no significant differences between the thera-
peutic management of suspected TB in chains and inde-
pendents. In terms of harmful medicines, shops rarely 
gave steroids, but 16% of chains and independents sold 
antibioticsi. A large proportion of chains and independ-
ents sold medicines that are not recommended for the 
treatment of TB: 63% and 62%, respectively. Over 50% 
i Top five antibiotics sold for suspected TB case: (1) amoxicillin; 
(2) azithromycin; (3) ciprofloxacin; (4) levofloxacin; (5) erythromycin.
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Table 3 History taking in chain and independent pharmacies when presented with cases of suspected TB and diarrhoea
Case Recommended questions
Chain (n=103)
% (95% CI)
Independent (n=230)
% (95% CI) p Value*
Suspected TB Consulted a doctor? 1.9 (0.5 to 7.5) 3.5 (1.7 to 6.8) 0.448
Chest pain? 1.0 (0.13 to 0.67) 2.6 (1.2 to 5.7) 0.336
Sputum or blood in cough? 11.7 (6.7 to 19.5) 13.5 (9.6 to 18.6) 0.646
Weakness or fatigue? 0 0.9 (0.2 to 3.4) 0.342
Weight loss? 0 0
Loss of appetite? 0 0
Chills? 0 0
Night sweats? 1.0 (0.1 to 0. 7) 1.7 (0.7 to 4.6) 0.594
Any other symptoms? 4.9 (2.0 to 11.2) 1.7 (0.7 to 4.6) 0.105
Tried any medication? 0 1.7 (0.7 to 4.6) 0.178
Asked any recommended 
questions?
16.5 (10.5 to 25.0) 22.6 (17.7 to 28.5) 0.204
Diarrhoea Blood in stool? 0 0
Duration of diarrhoea? 3.9 (1.5 to 10.0) 4.4 (2.4 to 7.9) 0.845
Number of stools per day? 4.9 (2.0 to 11.2) 2.2 (0.90 to 5.1) 0.185
Number of episodes of 
vomiting?
1.9 (0.5 to 7.5) 3.9 (2.0 to 7.4) 0.352
Presence of fever? 0 0.9 (0.2 to 3.4) 0.342
Preillness feeding practices? 0 0
Type of fluids and foods 
during illness?
0 0
Child passing urine? 0 0.4 (0.1 to 3.1) 0.503
Tried any medication? 0 0
Asked any recommended 
questions?
9.7 (5.3 to 17.2) 9.1 (6.0 to 13.6) 0.867
*Estimated by Pearson’s χ2 test.
of both shop types sold a schedule H medicine, although 
chains did not sell any of the more restricted H1 drugs. 
Seven independent shops (3%) sold H1 medicines (all 
of which were antibiotics). It is notable that not a single 
shop sold first-line anti-TB medicine. Figure 2 shows, of 
medicine sales, the proportion accounted for by each 
medicine category. The results are strikingly similar for 
chains and independents. Almost two-thirds of medicines 
sold were cold and/or cough preparations. The second 
and third most commonly sold medicines were antibi-
otics and antiasthma drugs, respectively.
No shops managed the case of childhood diarrhoea 
according to current guidelines (figure 3 and online 
supplementary appendix A2 for corresponding table). 
Further, no shops sold oral rehydration salts (ORS) 
and zinc together. The sale of zinc was extremely rare, 
recommended by only two chain shops (2%) and no 
independents (p=0.034). Only 12% of chains and 10% 
of independents sold ORT and in exactly half of these 
sales; this was alongside harmful medicines. A total of 
33% of chains and 42% of independents sold antibiotics. 
Antidiarrhoeal use was also higher in independents, 7% 
vs 2% for chains. Both antibiotics and antidiarrhoeals 
are considered harmful in the management of this case, 
and chains were found to sell significantly fewer of this 
combined category of harmful medicines (35% vs 48%, 
p=0.029). Antibioticsii or antidiarrhoeals accounted for 
nearly all the schedule H medicines sold; thus, we see 
significantly fewer chains selling schedule H medicines 
(37% vs 49%, p=0.045). H1 category medicine was sold 
by one independent pharmacy and no chains. A quarter 
of chains and 22% of independents sold treatments that 
are not recommended for diarrhoea. Although non-bac-
terial diarrhoea can be managed in the pharmacy, 41% 
of chains and 37% of independents referred the child to 
a doctor.
Of medicines sold for the patient with diarrhoea, 
worryingly, antibiotics made up the largest proportion 
for both chains and independents, 45% and 52%, respec-
tively (figure 4). Prebiotics and probiotics were popular, 
accounting for 32% of sales in chains and 26% in 
ii Top five antibiotics sold for diarrhoea case: (1) metronidazole+nor-
floxacin; (2) ofloxacin; (3) ofloxacin+ornidazole; (4) ofloxacin+metro-
nidazole; (5) metronidazole.
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Figure 1 Therapeutic management of suspected TB case by independent and chain pharmacies (see online supplementary 
appendix A1 for corresponding table). p Values were estimated using Pearson’s χ2 test. †Correct case management defined as 
referral without sale of any ‘harmful’ medicines (antibiotic or steroids). ‡We define ‘not recommended’ medicines as those not 
listed in the guidelines yet not deemed ‘harmful’. They include cough and/or cold medicines, analgesics and antiacid. 
Figure 2 Breakdown of medicines sold for suspected TB case by outlet type. May not add to 100% due to rounding. TB, 
tuberculosis.
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Figure 3 Therapeutic management of diarrhoea case by independent and chain pharmacies (see supplementary appendix 
A2 for corresponding table). p Values were estimated using Pearson’s χ2 test. †Correct case management defined as provision 
of ORS and zinc and no ‘harmful’ medicines (antibiotics, antidiarrhoeals or antispasmodics). ‡‘Not recommended’ medicines 
include prebiotics and probiotics, analgesics, antihelminitic and antiallergy. *Statistically significant at the 5% level. ORS, oral 
rehydration salts.
independents. ORT only accounted for 16% and 12% of 
sales in chains and independents, respectively.
We also demonstrated that the findings for treatment 
were unaffected after adjusting for any SP-specific effects 
(online supplementary appendix A3, 4).
Advice giving
Advice giving was uniformly limited. Only a handful of 
shops advised patients that TB treatment was available 
free of charge from the government (table 4). General 
advice for the fictitious child with diarrhoea was close to 
non-existent. While 41% of chains and 37% of independ-
ents referred the childhood diarrhoea case in the first 
instance, of the remaining shops, less than 1% of both 
shop types advised the SP to seek medical attention if 
they noticed any warning signs. One independent and 
no chains explained the importance of giving the child 
extra fluids to prevent dehydration. Advice regarding 
diet was similarly poor, given by 0.95% of chains and 
1.75% of independents. We only observed one significant 
difference in terms of advice giving. Of shops that did sell 
ORS, chains were found to offer an explanation of how 
to make up and use the solution in a larger proportion of 
interactions, 56% vs 10% for independents. The absolute 
numbers that provided ORS were, however, low.
dIscussIon
To our knowledge, this is the first study to compare the 
quality of all aspects of case management at chain and 
independent pharmacies for any condition in an LMIC 
setting. Using SPs provides an accurate picture of how 
pharmacy staff manage these conditions in everyday 
life, and the standardised presentation allows for direct 
comparison across pharmacies.29 Our results showed that 
the management of both cases did not live up to national 
or international standards, in either chains or independ-
ents. In terms of history taking, there were no significant 
differences between pharmacy types for either condition, 
and the level of questioning by pharmacy staff would not 
have elicited the required information to manage the SPs 
appropriately. We observed no significant differences in 
therapeutic management of the patient with suspected 
TB. Fewer than half of both shop types managed the case 
correctly by referring without selling any harmful medi-
cines. The one other SP study that has investigated how 
pharmacies respond to TB in India showed that anti-
biotic use substantially decreased when SPs presented 
with a known diagnosis, as opposed to just symptoms.27 
In our scenario, while SPs did not present with a medi-
cally confirmed diagnosis, they mentioned contact with 
an infected individual and hence a suggestion that they 
might have TB. This is more in line with a known diag-
nosis and our results are therefore likely presenting phar-
macy behaviour at the more positive end of the spectrum. 
As with all SP studies, our results reflect how pharmacies 
manage an unknown individual, and we cannot be sure 
this is the same as for regular customers.
Therapeutic management of the diarrhoea case was 
even worse than that of suspected TB. No pharmacies 
managed the case correctly. Chains did, however, sell 
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Figure 4 Breakdown of medicines sold for diarrhoea case by outlet type.
Table 4 Advice giving by chain and independent pharmacies
Case Advice
Chain (n=103)
% (95% CI)
Independent (n=230)
% (95% CI) p Value*
Suspected TB Treatment available free of charge from 
government hospital
1.0 (0.1 to 6.7) 1.7 (0.7 to 4.6) p=0.594
Diarrhoea Advised to visit doctor if any warning signs† 1.0 (0.1 to 6.7) 0.9 (0.2 to 3.4) p=0.928
Explained importance of giving extra fluids 0 0.5 (0.1 to 3.1) p=0.503
Gave advice regarding diet 1.0 (0.1 to 6.7) 1.8 (0.7 to 4.6) p=0.594
Chain (n=9) Independent (n=20)
Explain how to make up and use ORS? (of 
those providing)
55.6 (22.5 to 84.3) 10.0 (2.3 to 34.7) p=0.008*
*Estimated by Pearson’s χ2 test.
†This indicator excludes pharmacies that referred the patient to a medical practitioner as an initial course of action (see figure 2 for these 
data).
 ORS, oral rehydration salts.
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significantly more zinc and fewer medicines categorised 
as harmful. This translated into chains selling significantly 
fewer schedule H medicines. Advice giving was almost 
non-existent in both types of pharmacies. The lower sales 
of POMs for the patient with diarrhoea translated into 
significantly reduced cost of the diarrhoea consultation 
in chains compared with independent shops (draft in 
preparation). Further, given that patients are paying for 
their medicines out of pocket when seeking care at the 
pharmacy, we must note the unnecessary spending on 
both ‘not recommended’ and ‘harmful’ medicines.
The use of H1 medicines was scarce for both cases, 
but it is worth highlighting that not a single chain sold a 
medicine of this category (compared with eight indepen-
dents). This is an important finding, which corroborates 
the research of Satyanarayana and colleagues who report 
that pharmacies in other Indian cities (Mumbai, Patna 
and Delhi) also did not sell any first-line anti-TB medi-
cines when presented with an SP.27 Adherence to restric-
tions on the prescription of H1 medicines appears to be 
a positive finding for TB control efforts.
This study also brings to our attention the lack of guid-
ance for the treatment of minor ailments in the Indian 
(and other LMIC) pharmacy setting and highlights the 
grey area of how the management of conditions such 
as diarrhoea should be assessed. Considering the high 
proportion of childhood deaths accounted for by diar-
rhoea in India and the high utilisation of pharmacies, the 
development of pharmacy-specific treatment guidelines 
seems long overdue.
We report results from one city, raising the question 
of whether the findings are generalisable to other urban 
centres where chains operate. While other research has 
not focused on chains, our results add to a growing body 
of research in other areas of India that has used SP to 
assess quality of care for both pharmacies and other 
primary healthcare providers, including for childhood 
diarrhoea and TB. These other studies have shown 
quality of case management to be ubiquitously poor, 
regardless of whether patient first contact is with a phar-
macy, a medically qualified practitioner or an unqual-
ified, informal provider.27 30–32 Many of the chains in 
Bengaluru also operate in other Indian cities, where they 
would be likely to face similar incentives. Pharmacies 
across India operate under the same regulatory controls, 
and despite potential state-level variations in regulatory 
implementation, regulatory failure has been reported to 
be widespread across the country.33–37 Moreover, reviews 
have found striking similarities in the determinants of 
pharmacy provider behaviour in LMIC across countries 
and even continents,3 38 39 meaning that these results are 
potentially applicable to other LMIC settings with similar 
regulatory challenges. Other LMICs that have either an 
established or growing corporate pharmacy retail sector 
include Mexico, South Africa, Nigeria, Kenya, Uganda 
and the Philippines.8–10 Further study would be worth-
while to determine whether differences exist in other 
settings, where the business models for chains may differ.
While we report the results from the suspected TB and 
diarrhoea scenarios separately, SPs presented the details 
of the cases in a single encounter at each pharmacy, 
rather than the more common approach of using sepa-
rate interactions. Treatment results are in keeping with 
other studies that presented one of these conditions as 
a standalone case at pharmacies in India.27 40 We, there-
fore, have no reason to believe that pharmacy staff acted 
differently because SPs presented both cases in a single 
client interaction.
While no other studies have compared chain and 
independent pharmacies in terms of quality of care in 
an LMIC setting, Bennet and Yin examined the effect of 
chain store entry on prices and drug quality in Hyder-
abad, India.18 Through collaboration with a pharmacy 
chain, they gathered baseline data in markets the firm 
wished to enter and later resurveyed markets 1 year 
after market entry. The paper reported that, compared 
with independent retailers, chain prices were 6% lower 
and pharmacopoeia compliance (drug quality) was 6% 
higher. The resulting effect of chain entry on the market 
was a relative 5% improvement in drug quality and a 2% 
decrease in prices at existing retailers. If chain entry had 
led to similar spill over quality improvement effects in 
our study site, this would imply that our measured effect 
of a chain on quality would be biased towards zero. We do 
not have sufficient geographical data in order to deter-
mine whether the presence of a chain shop nearby alters 
the behaviour of independents, though this would be an 
interesting area for future research. However, a review of 
pharmacy practice in Asia reported similar management 
for various presentations of childhood diarrhoea going 
back 30 years, that is, before the advent of chains, indi-
cating that major changes in the behaviour of indepen-
dents do not appear to have occurred in recent times.3
The main difference between pharmacy types 
observed was the lower use by chains of harmful POMs 
for the patient with diarrhoea. There is evidence that 
some of these POMs, such as antibiotics, are high 
profit generators.41–43 Lower-powered financial incen-
tives faced by chain staff may explain a reduction in 
their use. Through in-depth interviews with chain and 
independent staff that we completed as a complement 
to this SP survey, we have been able to gain a more 
in-depth understanding of the behaviour of chains and 
independents (draft in preparation). We found that 
chain staff were heavily incentivised through a combi-
nation of sales targets and pressure from head-office 
and hence the incentives they faced were, in fact, not 
low powered. Additionally, these interviews revealed 
that profit-maximising strategies of chain employees 
tended to focus on improving customer experience, 
whereas independent owners focused on medicines 
sales. In addition to profit concerns, knowledge and 
regulation have also been shown to be important deter-
minants of pharmacy practice. Our qualitative work 
showed that stronger penalties for the provision of the 
more restricted medicine schedules have been effective 
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and some chains have instigated processes to ensure 
these rules are not broken (ibid). Chains use a number 
of methods to self-regulate and are able to control staff 
practices, but their main area of concern is customer 
satisfaction, rather than rational medicine use. Only a 
minority of chains had measures to monitor the sale 
of POMs at their outlets. In terms of knowledge, there 
appears to be little difference between knowledge of 
those working in chain and independent pharmacies. 
Even were there to be differences, it is well established 
that there is a large gap between what providers know 
and what they do in India, indicating that knowledge 
is necessary but not sufficient to ensure best prac-
tice.27 30–32 44
Our results provide a starting point for investigating 
how the organisation of the pharmacy firm affects 
provider behaviour in an LMIC setting. We did find 
small differences between the behaviour of chain staff 
and independent pharmacy owners. However, chains 
were far from fully addressing the quality deficiencies 
observed in the retail pharmacy sector, and it is unlikely 
that chains alone are going to solve persisting quality 
challenges. However, they may offer a potential vehicle 
through which to deliver interventions. Intervention 
initiatives reported in the literature include training, 
intensification of regulatory controls, peer review and 
accreditation.45–47 Some strategies, such as peer review 
and performance management, may have more impact 
within the structure of a chain. ‘League tables’ and 
‘naming and shaming’ have been used in high-income 
settings to influence prescribing behaviour of doctors 
working within a common organisation.48
conclusIon
The performance of chains and independent shops was 
equally poor for most areas of assessment. Our results 
indicate that, while in theory chains have the potential 
to improve treatment behaviour, in practice, they are 
unlikely to offer a magic bullet solution. However, impor-
tantly, we found that chains sold fewer prescription-only 
and harmful medicines to the patient with diarrhoea 
and successfully self-regulated the sale of H1 medicines. 
Future intervention research should consider recruiting 
chains to see whether intervention effectiveness differs 
among chains compared with independents.
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